Joe David Azzo, Marie-Joe Dib, Loukas Zagkos, Lei Zhao, Zhaoqing Wang, Ching-Pin Chang, Christina Ebert, Oday Salman, Sushrima Gan, Payman Zamani, Jordana B Cohen, Vanessa van Empel, A Mark Richards, Ali Javaheri, Douglas L Mann, Ernst R Rietzschel, Peter H Schafer, Dietmar A Seiffert, Dipender Gill, Stephen Burgess, Francisco Ramirez-Valle, David A Gordon, Thomas P Cappola, Julio A Chirinos
BACKGROUND: NT-proBNP (N-terminal pro-B-type natriuretic peptide) levels are variably elevated in heart failure with preserved ejection fraction (HFpEF), even in the presence of increased left ventricular filling pressures. NT-proBNP levels are prognostic in HFpEF and have been used as an inclusion criterion for several recent randomized clinical trials. However, the underlying biologic differences between HFpEF participants with high and low NT-proBNP levels remain to be fully understood...
February 1, 2024: Circulation. Heart Failure